EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Oleanolic acid alleviating ischemia-reperfusion injury in rat severe steatotic liver via KEAP1/NRF2/ARE

Yilin Pi, Huaiwen Zuo, Yuxin Wang, Weiping Zheng, Huiyuan Zhou, Lamei Deng, Hongli Song

International Immunopharmacology · 2024-09 · 138 · 112617

DOI: 10.1016/j.intimp.2024.112617 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024-09. Verfasst von Yilin Pi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin First Central Hospital Clinic Institute, Tianjin Medical University, Tianjin 300070, PR China. Electronic address: piyilin116@tmu.edu.cn. Hauptthemen laut MEDLINE: Fatty Liver, Gastrointestinal Microbiome, Kelch-Like ECH-Associated Protein 1, NF-E2-Related Factor 2. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe steatosis in donor livers is contraindicated for transplantation due to the high risk of ischemia-reperfusion injury (IRI). Although Ho-1 gene-modified bone marrow mesenchymal stem cells (HO-1/BMMSCs) can mitigate IRI, the role of gut microbiota and metabolites in this protection remains unclear. This study aimed to explore how gut microbiota and metabolites contribute to HO-1/BMMSCs-mediated protection against IRI in severe steatotic livers. Using rat models and cellular models (IAR20 and THLE-2 cells) of steatotic liver IRI, this study revealed that ischemia-reperfusion led to significant liver and intestinal damage, heightened immune responses, impaired liver function, and altered gut microbiota and metabolite profiles in rats with severe steatosis, which were partially reversed by HO-1/BMMSCs transplantation. Integrated microbiome and metabolome analyses identified gut microbial metabolite oleanolic acid as a potential protective agent against IRI. Experimental validation showed that oleanolic acid administration alone alleviated IRI and inhibited ferroptosis in both rat and cellular models. Network pharmacology and molecular docking implicated KEAP1/NRF2 pathway as a potential target of oleanolic acid. Indeed, OA experimentally upregulated NRF2 activity, which underlies its inhibition of ferroptosis and protection against IRI. The gut microbial metabolite OA protects against IRI in severe steatotic liver by promoting NRF2 expression and activity, thereby inhibiting ferroptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty LiverGastrointestinal MicrobiomeKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Oleanolic AcidReperfusion InjuryAnimalsHumansMaleRatsAntioxidant Response ElementsCell LineDisease Models, AnimalFerroptosisLiverMesenchymal Stem Cell TransplantationRats, Sprague-DawleySignal Transduction

Stichwörter der Autor:innen

FerroptosisGut microbial metabolitesIschemia–reperfusion injuryOleanolic acidSteatotic liver

Substanzen

KEAP1 protein, ratKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Nfe2l2 protein, ratOleanolic Acid

Autor:innen und Institutionen

  • Tianjin First Central Hospital Clinic Institute, Tianjin Medical University, Tianjin 300070, PR China. Electronic address: piyilin116@tmu.edu.cn.
  • Tianjin First Central Hospital Clinic Institute, Tianjin Medical University, Tianjin 300070, PR China. Electronic address: huaiwenzuo@tmu.edu.cn.
  • School of Medicine, Nankai University, Tianjin 300071, PR China. Electronic address: wangyuxin@tmu.edu.cn.
  • Department of Liver Transplantation, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin 300192, PR China; NHC Key Laboratory of Critical Care Medicine, Tianjin 300192, PR China. Electronic ad…
  • Tianjin First Central Hospital Clinic Institute, Tianjin Medical University, Tianjin 300070, PR China. Electronic address: zhouhuiyuan@tmu.edu.cn.
  • Tianjin First Central Hospital Clinic Institute, Tianjin Medical University, Tianjin 300070, PR China. Electronic address: dlm23@tmu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Pi, Y., Zuo, H., Wang, Y., Zheng, W., Zhou, H., Deng, L., & Song, H. (2024). Oleanolic acid alleviating ischemia-reperfusion injury in rat severe steatotic liver via KEAP1/NRF2/ARE. International Immunopharmacology, 138, 112617. https://doi.org/10.1016/j.intimp.2024.112617

Vancouver

Pi Y, Zuo H, Wang Y, Zheng W, Zhou H, Deng L, et al. Oleanolic acid alleviating ischemia-reperfusion injury in rat severe steatotic liver via KEAP1/NRF2/ARE. International Immunopharmacology. 2024;138:112617. doi:10.1016/j.intimp.2024.112617

BibTeX
@article{Pi2024,
  author = {Pi, Yilin and Zuo, Huaiwen and Wang, Yuxin and Zheng, Weiping and Zhou, Huiyuan and Deng, Lamei and Song, Hongli},
  title = {Oleanolic acid alleviating ischemia-reperfusion injury in rat severe steatotic liver via KEAP1/NRF2/ARE},
  journal = {International Immunopharmacology},
  year = {2024},
  volume = {138},
  pages = {112617},
  doi = {10.1016/j.intimp.2024.112617}
}
Kostenlos starten →